SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-014705
Filing Date
2017-08-02
Accepted
2017-08-01 18:01:10
Documents
51
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cort-10q_20170630.htm 10-Q 1206230
2 EX-31.1 cort-ex311_8.htm EX-31.1 15328
3 EX-31.2 cort-ex312_9.htm EX-31.2 15327
4 EX-32.1 cort-ex321_7.htm EX-32.1 6732
5 EX-32.2 cort-ex322_6.htm EX-32.2 6575
  Complete submission text file 0001564590-17-014705.txt   3877306

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cort-20170630.xml EX-101.INS 777470
7 XBRL TAXONOMY EXTENSION SCHEMA cort-20170630.xsd EX-101.SCH 29588
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20170630_cal.xml EX-101.CAL 44518
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cort-20170630_def.xml EX-101.DEF 44467
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20170630_lab.xml EX-101.LAB 206546
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20170630_pre.xml EX-101.PRE 151425
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 17997814
SIC: 2834 Pharmaceutical Preparations